Your Complete Guide to Global Clinical Research and GCP Compliance
Digital Tools, Platforms and Data Lakes to Power Novel Endpoint Development & Digital Biomarkers Digital Tools, Platforms and Data Lakes to Power Novel Endpoint Development & Digital Biomarkers In the rapidly evolving landscape of clinical research, especially for prostate cancer clinical trials, the integration of digital tools and innovative data management strategies plays a pivotal…
KPIs, Dashboards and Analytics to Measure Novel Endpoint Development & Digital Biomarkers Success KPIs, Dashboards and Analytics to Measure Novel Endpoint Development & Digital Biomarkers Success In recent years, the landscape of clinical trials has transformed significantly, especially with the introduction of novel endpoints and digital biomarkers. This article serves as a comprehensive guide, providing…
Global Regulatory Expectations Shaping Novel Endpoint Development & Digital Biomarkers in the US, EU and UK The landscape of clinical research is continuously evolving, particularly in the realm of new clinical trials focused on novel endpoints and the utilization of digital biomarkers. Regulatory authorities in the US, UK, and EU are increasingly recognizing the importance…
Partnering, Outsourcing and Alliances to Scale Novel Endpoint Development & Digital Biomarkers Partnering, Outsourcing and Alliances to Scale Novel Endpoint Development & Digital Biomarkers The pharmaceutical industry is in a transformative phase, driven by collaborative approaches that leverage novel endpoints and digital biomarkers. This article provides a comprehensive step-by-step guide for clinical operations, regulatory affairs,…
Common Pitfalls in Novel Endpoint Development & Digital Biomarkers—and How to Avoid Costly Rework Common Pitfalls in Novel Endpoint Development & Digital Biomarkers—and How to Avoid Costly Rework This comprehensive tutorial is designed for clinical operations, regulatory affairs, medical affairs, and R&D professionals engaged in pharmaceutical research and development. With the increasing trend towards utilizing…
Novel Endpoint Development & Digital Biomarkers: Strategic Playbook for Modern Pharma R&D Novel Endpoint Development & Digital Biomarkers: Strategic Playbook for Modern Pharma R&D In the evolving landscape of pharmaceutical research and development, the integration of novel endpoint development and digital biomarkers plays a pivotal role in enhancing the reliability and efficiency of clinical trials….
Novel Endpoint Development & Digital Biomarkers: Strategic Playbook for Modern Pharma R&D Novel Endpoint Development & Digital Biomarkers: Strategic Playbook for Modern Pharma R&D In the evolving landscape of clinical research, particularly within pharmaceutical R&D, the need for innovative approaches to endpoint development and a focus on digital biomarkers is paramount. As the industry adapts…
How to Design Novel Endpoint Development & Digital Biomarkers That Accelerates Time-to-Proof-of-Concept In the increasingly complex landscape of pharmaceutical research and development, the need for innovative strategies to streamline the drug development process has never been more critical. This is particularly true in the context of psychiatric disorders like schizophrenia, where traditional endpoints may not…
Novel Endpoint Development & Digital Biomarkers in Practice: Case Studies, Workflows and Governance Models In the rapidly evolving landscape of clinical research, novel endpoint development and the incorporation of digital biomarkers are becoming increasingly essential. Understanding how these elements are implemented within patient engagement and their significance in clinical trials can drastically enhance outcomes. This…
High-Impact Novel Endpoint Development & Digital Biomarkers Tactics That De-Risk Clinical Development The landscape of clinical trials is rapidly evolving, driven by innovations in science and technology. As clinical operations, regulatory affairs, medical affairs, and R&D professionals, it is imperative to stay abreast of high-impact strategies such as novel endpoint development and the integration of…